RadNet (RDNT) Liabilities and Shareholders Equity (2010 - 2026)
RadNet's (RDNT) quarterly Liabilities and Shareholders Equity came in at $4.2 billion in Q2 2026, up 20.24% year-over-year from $3.5 billion in Q2 2025, and up 8.78% quarter-over-quarter from $3.9 billion in Q1 2026.
Analysis
RadNet (RDNT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
RadNet has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $4.2 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 20.24% year-over-year to $4.2 billion; the TTM figure through Jun 2026 stood at $15.5 billion (up 15.82% YoY), while the FY2025 annual figure was $3.8 billion, up 14.36% from the prior year.
- Liabilities and Shareholders Equity came in at $4.2 billion for Q2 2026 at RadNet, up from $3.9 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.2 billion in Q2 2026 to a low of $2.1 billion in Q1 2022.
- Average Liabilities and Shareholders Equity over 5 years is $3.0 billion, with a median of $3.1 billion recorded in 2024.
- Year-over-year, Liabilities and Shareholders Equity increased 23.01% in 2024 and climbed 8.84% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $2.4 billion in 2022, then gained by 10.54% to $2.7 billion in 2023, then advanced by 22.16% to $3.3 billion in 2024, then rose by 14.36% to $3.8 billion in 2025, then rose by 12.45% to $4.2 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $4.2 billion in Q2 2026, $3.9 billion in Q1 2026, and $3.8 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn | 17.71 Bn |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn | 4.23 Bn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn | 3.01 Bn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - | 1.49 Bn |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - | 2.13 Bn |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn | 715.84 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn | 36.37 Bn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn | 8.05 Bn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn | 1.25 Bn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn | 178.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.23 Bn |
| Mar 31, 2026 | 3.89 Bn |
| Dec 31, 2025 | 3.76 Bn |
| Sep 30, 2025 | 3.67 Bn |
| Jun 30, 2025 | 3.51 Bn |
| Mar 31, 2025 | 3.34 Bn |
| Dec 31, 2024 | 3.29 Bn |
| Sep 30, 2024 | 3.28 Bn |
| Jun 30, 2024 | 3.23 Bn |
| Mar 31, 2024 | 2.97 Bn |
| Dec 31, 2023 | 2.69 Bn |
| Sep 30, 2023 | 2.69 Bn |
| Jun 30, 2023 | 2.71 Bn |
| Mar 31, 2023 | 2.41 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 2.25 Bn |
| Jun 30, 2022 | 2.24 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 2.06 Bn |
| Sep 30, 2021 | 2.04 Bn |